Cargando…

Long acting growth hormone (LAGH), an update

In 1957, Maurice Raben at Yale was able to isolate and purify growth hormone from cadaveric pituitary glands. Pituitary growth hormone was the only way to treat children with growth hormone (GH) deficiency, until 1985 when recombinant GH became available for daily subcutaneous injection. For many ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grillo, Margaret Steiner, Frank, Jacklyn, Saenger, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569466/ https://www.ncbi.nlm.nih.gov/pubmed/37842029 http://dx.doi.org/10.3389/fped.2023.1254231

Ejemplares similares

Long‐acting growth hormone in 2022
por: Steiner, Margaret, et al.
Publicado: (2023)

Update on Long-Acting Anticholinergics in Children and Adolescents With Difficult and Severe Asthma
por: Santamaria, Francesca, et al.
Publicado: (2022)

RF26 | PMON334 Once-Weekly Somapacitan in Growth Hormone Deficiency: 4-Year Efficacy and Safety Results from REAL 3, a Randomised Controlled Phase 2 Trial
por: Savendahl, Lars, et al.
Publicado: (2022)

SUN-247 Once-Weekly Somapacitan in Childhood Growth Hormone Deficiency: Efficacy and Safety Results of a Randomized, Open-Label, Controlled Phase 2 Trial (REAL 3)
por: Savendahl, Lars, et al.
Publicado: (2019)

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations
por: Christiansen, Jens Sandahl, et al.
Publicado: (2016)

OR10-05 Phase 3 FliGHt Trial: Experience of Switching from Daily Growth Hormone Therapy to Once-Weekly TransCon HGH in Children with Growth Hormone Deficiency
por: Maniatis, Aristides K, et al.
Publicado: (2020)

OR10-04 Interpretation of Insulin-like Growth Factor-1 (IGF-1) Levels Following Administration of Somatrogon (a Long-acting Human Growth Hormone - hGH-CTP)
por: Fisher, Dennis M, et al.
Publicado: (2020)

THU173 Subanalysis By Tanner Stage In Phase 3 Trials In Children And Adolescents With Growth Hormone Deficiency Treated With Lonapegsomatropin
por: Hofman, Paul, et al.
Publicado: (2023)

Current Status of Biosimilar Growth Hormone
por: Saenger, Paul
Publicado: (2009)

SAT-LB16 Maintenance of Favorable Treatment Effect of Once-Weekly TransCon hGH for Children With Growth Hormone Deficiency: Interim Analysis From the Enlighten Long-Term Extension Trial
por: Maniatis, Aristides K, et al.
Publicado: (2020)

Efficacy and Safety of up to 2 Years of Treatment With TransCon hGH (Lonapegsomatropin) in Treatment-Naïve and Treatment-Experienced Children With Growth Hormone Deficiency
por: Maniatis, Aristides K, et al.
Publicado: (2021)

Electrocardiographic Findings in Children With Growth Hormone Deficiency
por: Yılmaz, Münevver, et al.
Publicado: (2023)

SAT-LB15 24-Month Efficacy and Safety of Once Weekly and Every Other Week Administration of GX-H9, Hybrid FC-Fused Long-Acting Human Growth Hormone: A Phase 2 Study in Children With Growth Hormone Deficiency
por: Malievskiy, Oleg, et al.
Publicado: (2020)

RF26 | PMON332 Safety and Efficacy of Treatment with Lonapegsomatropin in Children with Growth Hormone Deficiency at Week 130 in the enliGHten Trial
por: Saenger, Paul, et al.
Publicado: (2022)

Ten years of biosimilar recombinant human growth hormone in Europe
por: Saenger, Paul
Publicado: (2017)

Quality of Life of Short-Statured Children Born Small for Gestational Age or Idiopathic Growth Hormone Deficiency Within 1 Year of Growth Hormone Treatment
por: Quitmann, Julia, et al.
Publicado: (2019)

Psycho-Emotional and Behavioral Problems in Children With Growth Hormone Deficiency
por: Aryayev, Mykola, et al.
Publicado: (2021)

OR17-4 Transcon Growth Hormone In The Treatment Of Pediatric Growth Hormone Deficiency: Results Of The Phase 3 Height Trial
por: Thornton, Paul, et al.
Publicado: (2019)

Long-Term Growth Hormone Therapy Does Not Advance Skeletal Maturation in Children and Adolescents
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021)

Growth Hormone Stimulation Testing Patterns Contribute to Gender Disparities in Growth Hormone Treatment
por: Kamoun, Camilia, et al.
Publicado: (2021)

Congenital Long QT Syndrome: An Update and Present Perspective in Saudi Arabia
por: Bhuiyan, Zahurul A., et al.
Publicado: (2013)

Factors Driving Patient Preferences for Growth Hormone Treatment in Japanese Children With Growth Hormone Deficiency
por: Tanaka, Toshiaki, et al.
Publicado: (2021)

OR10-06 Somatrogon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Pivotal Pediatric Phase 3 Clinical Trial
por: Deal, Cheri L, et al.
Publicado: (2020)

PSAT104 Predicting Response to Growth Hormone Therapy with Pituitary Volume and The Growth Hormone Stimulation Test
por: McGuirk, Liam, et al.
Publicado: (2022)

Monitoring Cerebral Oxygenation in Neonates: An Update
por: Dix, Laura Marie Louise, et al.
Publicado: (2017)

Gut microbiota composition alteration analysis and functional categorization in children with growth hormone deficiency
por: Huang, Congfu, et al.
Publicado: (2023)

Updates on pediatric sepsis
por: Cruz, Andrea T., et al.
Publicado: (2020)

ODP392 Persistence with daily growth hormone treatment among pediatric patients with growth hormone deficiency in the UK
por: Loftus, Jane, et al.
Publicado: (2022)

Corrigendum: Monitoring Cerebral Oxygenation in Neonates: An Update
por: Dix, Laura Marie Louise, et al.
Publicado: (2017)

Effects of different doses of long-acting growth hormone in treating children with growth hormone deficiency
por: Xia, Wei, et al.
Publicado: (2023)

Oral testosterone undecanoate is an effective treatment for micropenis therapy
por: Saenger, Paul, et al.
Publicado: (2021)

Reduced circulating growth hormone and insulin-like growth factor-1 and delayed growth of premature rats are aggravated by longer daily duration of chronic intermittent hypoxia exposure
por: Zhang, Chi, et al.
Publicado: (2023)

Clinical and hormonal characteristics and growth data of 45,X/46,XY mosaicism in 38 Chinese patients
por: Yang, Jiaoru, et al.
Publicado: (2023)

Floating-Harbor Syndrome Treated With Recombinant Human Growth Hormone: A Case Report and Literature Review
por: Bo, Hui, et al.
Publicado: (2021)

Case Report: Glycogen Storage Disease Type Ia in a Chinese Child Treated With Growth Hormone
por: Wu, Shimin, et al.
Publicado: (2022)

Childhood Hypercalciuric Hypercalcemia With Elevated Vitamin D and Suppressed Parathyroid Hormone: Long-Term Follow Up
por: Gurevich, Evgenia, et al.
Publicado: (2021)

ODP386 Growth Velocity and Growth Hormone Deficiency During Puberty
por: Currais, Carolina, et al.
Publicado: (2022)

Perspectives on long-acting growth hormone therapy in children and adults
por: Lal, Rayhan A., et al.
Publicado: (2019)

Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs
por: Yuen, Kevin C. J., et al.
Publicado: (2021)

Economic Burden of Growth Hormone Deficiency in a US Pediatric Population
por: Kaplowitz, Paul B, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4u7i0ttqll26pemlp8i4cavlpi